Terms: = Endocrine gland cancer AND GATA2, NFE1B, 2624, ENSG00000179348, MGC2306, P23769 AND Treatment
4 results:
1. Overview of the 2022 WHO Classification of Pituitary Adenomas/Pituitary Neuroendocrine Tumors: Clinical Practices, Controversies, and Perspectives.
Wan XY; Chen J; Wang JW; Liu YC; Shu K; Lei T
Curr Med Sci; 2022 Dec; 42(6):1111-1118. PubMed ID: 36544040
[TBL] [Abstract] [Full Text] [Related]
2. Current medical treatment and perspective in gonadotroph tumors.
Even-Zohar N; Greenman Y
Best Pract Res Clin Endocrinol Metab; 2022 Dec; 36(6):101685. PubMed ID: 35871905
[TBL] [Abstract] [Full Text] [Related]
3. 5-AZA-dC induces epigenetic changes associated with modified glycosylation of secreted glycoproteins and increased EMT and migration in chemo-sensitive cancer cells.
Greville G; Llop E; Howard J; Madden SF; Perry AS; Peracaula R; Rudd PM; McCann A; Saldova R
Clin Epigenetics; 2021 Feb; 13(1):34. PubMed ID: 33579350
[TBL] [Abstract] [Full Text] [Related]
4. Conservative surgery in ovarian borderline tumours: a meta-analysis with emphasis on recurrence risk.
Vasconcelos I; de Sousa Mendes M
Eur J Cancer; 2015 Mar; 51(5):620-31. PubMed ID: 25661104
[TBL] [Abstract] [Full Text] [Related]
